Evidence-based MAT and behavioral therapy for opioid use disorder in Los Angeles
Opioid addiction changes the brain. It doesn’t matter how it started — a pain prescription that escalated, or heroin or fentanyl from the street. Once the brain’s reward system adapts, stopping without help is extremely hard. That’s not weakness. It’s biology — and it’s treatable.
The most effective approach combines medication with therapy. That’s what we provide: buprenorphine (Suboxone) managed by our medical team, plus individual therapy, group sessions, and holistic support. Treatment runs as PHP (full weekdays — you sleep at home) or IOP (a few 3-hour sessions a week, with morning and evening tracks). Most of our clients keep working during treatment.
Start Recovery Today
Buprenorphine (Suboxone) is one of the most effective medications for opioid use disorder. It eases withdrawal, reduces cravings, blocks the effects of other opioids, and substantially reduces overdose risk — all while allowing you to function normally in daily life.
For patients who prefer a non-opioid option after completing detox, extended-release naltrexone (Vivitrol) blocks opioid receptors, eliminating the reward from any opioid use and supporting sustained abstinence-based recovery.
CBT addresses the triggers, thought patterns, and coping deficits that drive opioid use. You'll develop practical strategies to navigate cravings, high-risk situations, and the emotional states that previously led to use.
Evidence-based positive reinforcement strategies that reward negative drug tests and treatment attendance — one of the most effective behavioral interventions for opioid use disorder available.
Opioid-focused group sessions provide peer support, accountability, and the normalizing experience of connecting with others who understand the unique challenges of opioid recovery.
Opioid use disorder frequently co-occurs with trauma and PTSD. Our trauma-informed approach ensures that underlying trauma is identified and treated concurrently — not sequentially — as part of comprehensive care.
Despite its proven effectiveness, MAT is still misunderstood. Some treatment programs discourage or prohibit it — a position that contradicts decades of research and clinical guidelines. Here's what the evidence actually shows:
Sources: NIDA — Medications to Treat Opioid Use Disorder Research Report, SAMHSA — Medications for Substance Use Disorders, CDC — Overdose Prevention.
Usually there’s no separate detox stay. Buprenorphine (Suboxone) itself relieves withdrawal, so many people begin medication early in outpatient treatment. Because fentanyl stays in the body longer than other opioids, our medical team uses a careful, fentanyl-aware start. A free assessment tells us what’s safe for you.
Yes. Most of our clients keep working or attending school. Our IOP (a few 3-hour sessions a week — you sleep at home) has morning and evening tracks, and telehealth is available for many sessions.
Not from us. Your records are protected by HIPAA and 42 CFR Part 2 — a federal confidentiality law written specifically for substance use treatment. We never contact your employer, and nothing is shared without your written consent.
No. Buprenorphine is medicine for a medical condition. At a steady prescribed dose it doesn’t make you high — it relieves withdrawal and cravings so therapy can work. SAMHSA, the CDC, and the American Society of Addiction Medicine all support its use.
It depends on your plan. We accept most major insurance, and under federal parity law and California’s SB 855, health plans must cover medically necessary addiction care. Verifying your benefits is free and confidential — you’ll know your costs before you start.
Coverage varies by plan. Our admissions team verifies your exact benefits for free and explains your options honestly, without pressure.
Insurance logos are shown to help you identify your plan and are trademarks of their respective owners; they do not imply endorsement. Coverage varies by plan — verification is free and confidential.